Zimmer Biomet beats estimates but cautious 2026 guidance weighs on shares
Zimmer Biomet Holdings (NYSE:ZBH) reported fourth-quarter results on Tuesday, February 10, 2026, that exceeded Wall Street expectations, though the medical device giant’s shares remained under pressure following a "cautious" outlook for the coming fiscal year.























